DD218632A5 - Verfahren zur herstellung von interleukin-2 - Google Patents

Verfahren zur herstellung von interleukin-2 Download PDF

Info

Publication number: DD218632A5
Authority: DD; German Democratic Republic
Prior art keywords: sequence; gene; dna; cdna; cells
Prior art date: 1982-12-15

Application number

DD25780883A

Other languages

German (de)

English (en)

Inventor

Tadatsugu Taniguchi

Masami Muramatsu

Haruo Sugano

Hiroshi Matsui

Nobukazu Kashima

Junji Hamuro

Original Assignee

Ajinomoto Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-12-15

Filing date

1983-12-12

Publication date

1985-02-13

1982-12-15 Priority claimed from JP57219518A external-priority patent/JPS59140878A/ja

1982-12-24 Priority claimed from JP57229619A external-priority patent/JPS59140882A/ja

1982-12-27 Priority claimed from JP57234607A external-priority patent/JPS59140898A/ja

1982-12-29 Priority claimed from JP57230371A external-priority patent/JPS59140897A/ja

1983-02-03 Priority claimed from EP83101035A external-priority patent/EP0091539B2/en

1983-12-12 Application filed by Ajinomoto Gmbh filed Critical Ajinomoto Gmbh

1985-02-13 Publication of DD218632A5 publication Critical patent/DD218632A5/de

Links

108010002350 Interleukin-2 Proteins 0.000 title claims abstract description 204
102000000588 Interleukin-2 Human genes 0.000 title claims abstract description 200
238000000034 method Methods 0.000 title claims abstract description 72
230000008569 process Effects 0.000 title description 6
238000002360 preparation method Methods 0.000 title description 3
210000004027 cell Anatomy 0.000 claims abstract description 147
108020004414 DNA Proteins 0.000 claims abstract description 106
108090000623 proteins and genes Proteins 0.000 claims abstract description 78
230000000694 effects Effects 0.000 claims abstract description 50
239000013598 vector Substances 0.000 claims abstract description 29
108020004511 Recombinant DNA Proteins 0.000 claims abstract description 23
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 22
229920001184 polypeptide Polymers 0.000 claims abstract description 21
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 21
210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 14
210000001236 prokaryotic cell Anatomy 0.000 claims abstract description 10
108020004999 messenger RNA Proteins 0.000 claims description 74
241000588724 Escherichia coli Species 0.000 claims description 38
210000001744 T-lymphocyte Anatomy 0.000 claims description 22
239000001963 growth medium Substances 0.000 claims description 20
210000004962 mammalian cell Anatomy 0.000 claims description 14
230000010076 replication Effects 0.000 claims description 12
108091008146 restriction endonucleases Proteins 0.000 claims description 12
108091026890 Coding region Proteins 0.000 claims description 8
241000282693 Cercopithecidae Species 0.000 claims description 5
108091034057 RNA (poly(A)) Proteins 0.000 claims description 3
239000013049 sediment Substances 0.000 claims description 3
101710128836 Large T antigen Proteins 0.000 claims description 2
210000004408 hybridoma Anatomy 0.000 claims description 2
238000011144 upstream manufacturing Methods 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 3
241000235070 Saccharomyces Species 0.000 claims 2
241000588722 Escherichia Species 0.000 claims 1
102000015696 Interleukins Human genes 0.000 claims 1
108010063738 Interleukins Proteins 0.000 claims 1
229940047122 interleukins Drugs 0.000 claims 1
238000012258 culturing Methods 0.000 abstract description 2
230000003362 replicative effect Effects 0.000 abstract description 2
108020004635 Complementary DNA Proteins 0.000 description 126
238000010804 cDNA synthesis Methods 0.000 description 123
239000002299 complementary DNA Substances 0.000 description 123
239000013612 plasmid Substances 0.000 description 85
150000001413 amino acids Chemical group 0.000 description 37
239000012634 fragment Substances 0.000 description 37
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 35
235000001014 amino acid Nutrition 0.000 description 24
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 20
239000000243 solution Substances 0.000 description 20
239000002609 medium Substances 0.000 description 19
239000002585 base Substances 0.000 description 18
238000003776 cleavage reaction Methods 0.000 description 18
235000018102 proteins Nutrition 0.000 description 18
102000004169 proteins and genes Human genes 0.000 description 18
230000007017 scission Effects 0.000 description 18
239000011780 sodium chloride Substances 0.000 description 18
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 17
101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 17
230000015572 biosynthetic process Effects 0.000 description 17
240000004808 Saccharomyces cerevisiae Species 0.000 description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
102000004594 DNA Polymerase I Human genes 0.000 description 14
108010017826 DNA Polymerase I Proteins 0.000 description 14
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 14
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 14
239000003226 mitogen Substances 0.000 description 14
210000004698 lymphocyte Anatomy 0.000 description 12
239000000047 product Substances 0.000 description 12
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
230000001580 bacterial effect Effects 0.000 description 11
241001131785 Escherichia coli HB101 Species 0.000 description 10
238000001890 transfection Methods 0.000 description 10
238000005119 centrifugation Methods 0.000 description 9
239000000203 mixture Substances 0.000 description 9
239000000523 sample Substances 0.000 description 9
230000014616 translation Effects 0.000 description 9
238000013519 translation Methods 0.000 description 9
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 8
238000000246 agarose gel electrophoresis Methods 0.000 description 8
229960000723 ampicillin Drugs 0.000 description 8
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 8
239000012894 fetal calf serum Substances 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
238000012360 testing method Methods 0.000 description 8
101150099542 tuf gene Proteins 0.000 description 8
101150010742 tuf2 gene Proteins 0.000 description 8
101150056072 TUFB gene Proteins 0.000 description 7
239000000872 buffer Substances 0.000 description 7
235000013601 eggs Nutrition 0.000 description 7
230000012010 growth Effects 0.000 description 7
238000003780 insertion Methods 0.000 description 7
230000037431 insertion Effects 0.000 description 7
239000013600 plasmid vector Substances 0.000 description 7
239000006228 supernatant Substances 0.000 description 7
230000009466 transformation Effects 0.000 description 7
101150071165 tuf1 gene Proteins 0.000 description 7
108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
108020004705 Codon Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
238000009395 breeding Methods 0.000 description 6
230000001488 breeding effect Effects 0.000 description 6
238000010276 construction Methods 0.000 description 6
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 6
239000013613 expression plasmid Substances 0.000 description 6
FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 6
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
229940041514 candida albicans extract Drugs 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
210000004748 cultured cell Anatomy 0.000 description 5
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 5
239000000284 extract Substances 0.000 description 5
238000009396 hybridization Methods 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
239000012138 yeast extract Substances 0.000 description 5
GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 4
NCMVOABPESMRCP-SHYZEUOFSA-N 2'-deoxycytosine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 NCMVOABPESMRCP-SHYZEUOFSA-N 0.000 description 4
108020004774 Alkaline Phosphatase Proteins 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 4
102000012410 DNA Ligases Human genes 0.000 description 4
108010061982 DNA Ligases Proteins 0.000 description 4
102100031780 Endonuclease Human genes 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
229920005654 Sephadex Polymers 0.000 description 4
239000012507 Sephadex™ Substances 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
239000004098 Tetracycline Substances 0.000 description 4
230000003213 activating effect Effects 0.000 description 4
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 4
239000001913 cellulose Substances 0.000 description 4
229920002678 cellulose Polymers 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 4
238000000432 density-gradient centrifugation Methods 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
238000000605 extraction Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
230000007774 longterm Effects 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
230000003287 optical effect Effects 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
230000028327 secretion Effects 0.000 description 4
229960002180 tetracycline Drugs 0.000 description 4
229930101283 tetracycline Natural products 0.000 description 4
235000019364 tetracycline Nutrition 0.000 description 4
150000003522 tetracyclines Chemical class 0.000 description 4
229940104230 thymidine Drugs 0.000 description 4
239000003981 vehicle Substances 0.000 description 4
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108010050904 Interferons Proteins 0.000 description 3
102000014150 Interferons Human genes 0.000 description 3
108090001090 Lectins Proteins 0.000 description 3
102000004856 Lectins Human genes 0.000 description 3
102000016943 Muramidase Human genes 0.000 description 3
108010014251 Muramidase Proteins 0.000 description 3
241001529936 Murinae Species 0.000 description 3
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
108010076504 Protein Sorting Signals Proteins 0.000 description 3
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 3
108091081024 Start codon Proteins 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
239000000654 additive Substances 0.000 description 3
239000000427 antigen Substances 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
238000003556 assay Methods 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
239000003636 conditioned culture medium Substances 0.000 description 3
239000012228 culture supernatant Substances 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
239000003599 detergent Substances 0.000 description 3
239000003814 drug Substances 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000008103 glucose Substances 0.000 description 3
230000002209 hydrophobic effect Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
229940047124 interferons Drugs 0.000 description 3
230000004073 interleukin-2 production Effects 0.000 description 3
239000002523 lectin Substances 0.000 description 3
208000032839 leukemia Diseases 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
229960000274 lysozyme Drugs 0.000 description 3
239000004325 lysozyme Substances 0.000 description 3
235000010335 lysozyme Nutrition 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
238000000520 microinjection Methods 0.000 description 3
210000000287 oocyte Anatomy 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
229960005322 streptomycin Drugs 0.000 description 3
239000005720 sucrose Substances 0.000 description 3
238000010257 thawing Methods 0.000 description 3
LTFMZDNNPPEQNG-KVQBGUIXSA-N 2'-deoxyguanosine 5'-monophosphate Chemical group C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 LTFMZDNNPPEQNG-KVQBGUIXSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
229920001817 Agar Polymers 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
235000014469 Bacillus subtilis Nutrition 0.000 description 2
108010062580 Concanavalin A Proteins 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
241000701533 Escherichia virus T4 Species 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
108010015133 Galactose oxidase Proteins 0.000 description 2
108091005904 Hemoglobin subunit beta Proteins 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
108091036060 Linker DNA Proteins 0.000 description 2
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
102000005348 Neuraminidase Human genes 0.000 description 2
108010006232 Neuraminidase Proteins 0.000 description 2
108091028043 Nucleic acid sequence Proteins 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
-1 PMA or TPA Chemical class 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
208000000389 T-cell leukemia Diseases 0.000 description 2
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 2
101100002024 Thermus aquaticus pstI gene Proteins 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
241000209140 Triticum Species 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
241000269370 Xenopus <genus> Species 0.000 description 2
241000269368 Xenopus laevis Species 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
239000008272 agar Substances 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
230000003321 amplification Effects 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
239000012911 assay medium Substances 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
101150006308 botA gene Proteins 0.000 description 2
229960005091 chloramphenicol Drugs 0.000 description 2
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
125000000086 dCMP group Chemical group 0.000 description 2
LTFMZDNNPPEQNG-UHFFFAOYSA-N deoxyguanylic acid Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(COP(O)(O)=O)O1 LTFMZDNNPPEQNG-UHFFFAOYSA-N 0.000 description 2
230000029087 digestion Effects 0.000 description 2
238000003113 dilution method Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000010828 elution Methods 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
210000004349 growth plate Anatomy 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
208000026278 immune system disease Diseases 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000000411 inducer Substances 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
244000005700 microbiome Species 0.000 description 2
210000004897 n-terminal region Anatomy 0.000 description 2
210000000822 natural killer cell Anatomy 0.000 description 2
230000001613 neoplastic effect Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
239000012898 sample dilution Substances 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000013605 shuttle vector Substances 0.000 description 2
210000004989 spleen cell Anatomy 0.000 description 2
239000000021 stimulant Substances 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
238000005406 washing Methods 0.000 description 2
235000005074 zinc chloride Nutrition 0.000 description 2
239000011592 zinc chloride Substances 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
KHWCHTKSEGGWEX-RRKCRQDMSA-N 2'-deoxyadenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(O)=O)O1 KHWCHTKSEGGWEX-RRKCRQDMSA-N 0.000 description 1
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
244000144725 Amygdalus communis Species 0.000 description 1
235000011437 Amygdalus communis Nutrition 0.000 description 1
241000024188 Andala Species 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
210000003771 C cell Anatomy 0.000 description 1
101100479039 Caenorhabditis elegans aars-1 gene Proteins 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
108090000204 Dipeptidase 1 Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
101100232904 Homo sapiens IL2 gene Proteins 0.000 description 1
108090000144 Human Proteins Proteins 0.000 description 1
102000003839 Human Proteins Human genes 0.000 description 1
101150103227 IFN gene Proteins 0.000 description 1
101150083678 IL2 gene Proteins 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
102000000589 Interleukin-1 Human genes 0.000 description 1
108010002352 Interleukin-1 Proteins 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102000013967 Monokines Human genes 0.000 description 1
108010050619 Monokines Proteins 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
101710149086 Nuclease S1 Proteins 0.000 description 1
229940122426 Nuclease inhibitor Drugs 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
108010058860 P.polypeptide Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
108020005091 Replication Origin Proteins 0.000 description 1
241000220317 Rosa Species 0.000 description 1
102000040739 Secretory proteins Human genes 0.000 description 1
108091058545 Secretory proteins Proteins 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108010092262 T-Cell Antigen Receptors Proteins 0.000 description 1
206010042971 T-cell lymphoma Diseases 0.000 description 1
208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
230000001594 aberrant effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
239000003513 alkali Substances 0.000 description 1
235000020224 almond Nutrition 0.000 description 1
230000003698 anagen phase Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
102000006635 beta-lactamase Human genes 0.000 description 1
230000004791 biological behavior Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
238000012832 cell culture technique Methods 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000000139 costimulatory effect Effects 0.000 description 1
239000012531 culture fluid Substances 0.000 description 1
108091092330 cytoplasmic RNA Proteins 0.000 description 1
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
KHWCHTKSEGGWEX-UHFFFAOYSA-N deoxyadenylic acid Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(O)=O)O1 KHWCHTKSEGGWEX-UHFFFAOYSA-N 0.000 description 1
KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
229960003964 deoxycholic acid Drugs 0.000 description 1
KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
210000003162 effector t lymphocyte Anatomy 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
108010092809 exonuclease Bal 31 Proteins 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000011049 filling Methods 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000006870 function Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000003365 glass fiber Substances 0.000 description 1
108060003196 globin Proteins 0.000 description 1
239000007973 glycine-HCl buffer Substances 0.000 description 1
238000003505 heat denaturation Methods 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
102000055277 human IL2 Human genes 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
229910052588 hydroxylapatite Inorganic materials 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000000760 immunoelectrophoresis Methods 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
238000007901 in situ hybridization Methods 0.000 description 1
238000012606 in vitro cell culture Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000003999 initiator Substances 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
231100000518 lethal Toxicity 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000005567 liquid scintillation counting Methods 0.000 description 1
238000011068 loading method Methods 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000010841 mRNA extraction Methods 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
238000010297 mechanical methods and process Methods 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
150000004633 phorbol derivatives Chemical class 0.000 description 1
239000002644 phorbol ester Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
HJRIWDYVYNNCFY-UHFFFAOYSA-M potassium;dimethylarsinate Chemical compound [K+].C[As](C)([O-])=O HJRIWDYVYNNCFY-UHFFFAOYSA-M 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
YVSWPCCVTYEEHG-UHFFFAOYSA-N rhodamine B 5-isothiocyanate Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(N=C=S)C=C1C(O)=O YVSWPCCVTYEEHG-UHFFFAOYSA-N 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
239000002342 ribonucleoside Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
210000004988 splenocyte Anatomy 0.000 description 1
108010075210 streptolysin O Proteins 0.000 description 1
238000000856 sucrose gradient centrifugation Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000003151 transfection method Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
238000003569 transporter assay Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
125000005287 vanadyl group Chemical group 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

Landscapes

Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DD25780883A 1982-12-15 1983-12-12 Verfahren zur herstellung von interleukin-2 DD218632A5 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP57219518A JPS59140878A (ja)	1982-12-15	1982-12-15	組換え体微生物
JP57229619A JPS59140882A (ja)	1982-12-24	1982-12-24	インターロイキン２活性をもつポリペプチドをコードする遺伝子
JP57234607A JPS59140898A (ja)	1982-12-27	1982-12-27	インタ−ロイキン−２の製造法
JP57230371A JPS59140897A (ja)	1982-12-29	1982-12-29	インタ−ロイキン−２の製造方法
EP83101035A EP0091539B2 (en)	1982-03-31	1983-02-03	Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells

Publications (1)

Publication Number	Publication Date
DD218632A5 true DD218632A5 (de)	1985-02-13

Family

ID=27513246

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD25780883A DD218632A5 (de)	1982-12-15	1983-12-12	Verfahren zur herstellung von interleukin-2

Country Status (5)

Country	Link
AT (1)	AT392082B (da)
AU (1)	AU556353B2 (da)
DD (1)	DD218632A5 (da)
DK (1)	DK173788B1 (da)
HU (1)	HU197938B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU579089B2 (en) *	1983-02-08	1988-11-17	Biogen, Inc.	Human interleukin-2-like polypeptides
WO1985000606A1 (fr) *	1983-07-19	1985-02-14	Takeda Chemical Industries, Ltd.	Il-2 humaine et son procede de preparation
EP0177357A1 (en) *	1984-10-05	1986-04-09	Schering Biotech Corporation	cDNA Clones coding for polypeptides exhibiting murine interleukin-2 activity
US4992367A (en) *	1986-05-12	1991-02-12	Hoffmann-La Roche Inc.	Enhanced expression of human interleukin-2 in mammalian cells

1983
- 1983-11-17 AU AU21472/83A patent/AU556353B2/en not_active Expired
- 1983-12-12 DD DD25780883A patent/DD218632A5/de unknown
- 1983-12-14 AT AT435083A patent/AT392082B/de active
- 1983-12-14 DK DK577283A patent/DK173788B1/da not_active IP Right Cessation
- 1983-12-14 HU HU426383A patent/HU197938B/hu unknown

Also Published As

Publication number	Publication date
HU197938B (en)	1989-06-28
DK577283D0 (da)	1983-12-14
DK173788B1 (da)	2001-10-22
AU556353B2 (en)	1986-10-30
AU2147283A (en)	1984-06-21
AT392082B (de)	1991-01-25
DK577283A (da)	1984-06-16
ATA435083A (de)	1990-07-15

Publication	Publication Date	Title
EP0091539B2 (en)	1996-11-27	Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
DE3238554C2 (da)	1989-11-23
EP0099084B1 (de)	1989-05-31	Verfahren zur Herstellung von Interferon und Expressionsvektoren dafür
DE3588199T2 (de)	1999-04-08	Lymphokin-Herstellung und -Reinigung
DE3177288T3 (de)	2000-03-16	Reife menschliche Leukozyten-Interferone, Verfahren zu ihrer bacteriellen Herstellung, Zwischenprodukte hierfür und Zusammensetzungen diese enthaltend.
DE3486216T2 (de)	1994-02-17	Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren.
DE3586335T2 (de)	1993-01-14	Herstellung von gamma-interferon.
DE3786767T3 (de)	1998-04-16	Neues Polypeptid.
DE3750113T2 (de)	1994-11-24	Für menschliche "Colony-stimulating"-Faktoren kodierendes Gen.
DE3382575T2 (de)	1993-02-11	Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung von schweinewachstumshormonaehnlichen polypeptiden.
DD209652A5 (de)	1984-05-16	Verfahren zur herstellung eines replikablen vektors
CH663032A5 (de)	1987-11-13	Doppelstraengige dna, replizierbare plasmidische expressionstraeger zur mikrobiellen herstellung von hybrid human-leukozyten-interferon und transformierte mikroorganismen.
EP0147819B1 (de)	1992-06-03	Reinigung von rekombinanten Interleukin-2
DD212748A5 (de)	1984-08-22	Verfahren zur bildung doppelstraengiger, hybride human-leukozyten-interferone kodierender dns
DE3588224T2 (de)	2001-10-25	Gereinigtes Interleukin-1 und für Interleukin-1 kodierende DNS und deren Herstellung, solche DNS enthaltende Vektoren und deren Herstellung und Verwendung zum Transformieren von Wirten, die die Expression von Interleukin-1 zulassen
DE3382789T2 (de)	1995-12-14	Tierische Interferone, Verfahren bei deren Herstellung, dieselben enthaltende Zusammensetzungen, kodierende DNS-Sequenzen hierfür und diese Sequenzen enthaltende Expressionsvektoren und dadurch transformierte Zellen.
DE3851035T2 (de)	1994-12-01	Interleukin-7.
DE3586826T2 (de)	1993-03-25	Cdna-klone, kodierend fuer peptide mit der wirksamkeit eines menschlichen granulocyte-, makrophage- und eosinophilzellenwachstumsfaktors.
DE3642096A1 (de)	1988-06-16	Pferde-(gamma)-interferon
EP0170204B1 (de)	1991-09-25	Neue genetische Sequenzen, die durch sie codierten Interferon-Peptide vom Typ I und diese sie produzierende Organismen
DE3247922A1 (de)	1984-06-28	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3886395T2 (de)	1994-04-21	RINDER-INTERLEUKIN-1-g(b).
DE3750348T2 (de)	1994-12-15	Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
DD218632A5 (de)	1985-02-13	Verfahren zur herstellung von interleukin-2
AT394209B (de)	1992-02-25	Verfahren zur herstellung neuer mikroorganismen zur produktion von hybriden human-leukozyten-interferonen